Dynasty Wealth Management’s Ionis Pharmaceuticals IONS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$632K Buy
14,162
+501
+4% +$28.5K ﹤0.01% 216
2026
Q2
$1.08M Sell
13,661
-419
-3% -$31.5K 0.01% 186
2026
Q1
$1.06M Buy
14,080
+90
+0.6% +$7.1K 0.01% 179
2025
Q4
$1.11M Sell
13,990
-351
-2% -$26.4K 0.01% 178
2025
Q3
$938K Buy
+14,341
New +$700K 0.01% 170

Other funds holding IONS

Dynasty Wealth Management's IONS Position: Q3 2026 in Review

Dynasty Wealth Management increased its Ionis Pharmaceuticals (IONS) stake by 3.7% in Q3 2026, buying an estimated $28.5K and bringing the position to 14,162 shares worth $632K. The position accounts for ﹤0.01% of the portfolio, ranked #216.

Dynasty Wealth Management first reported a position in IONS in Q3 2025 and has held it in 5 quarters since. The position peaked at $1.11M in Q4 2025. 458 funds tracked by Wall St. Rank hold IONS as of Q3 2026.

  • Dynasty Wealth Management held 14,162 shares of Ionis Pharmaceuticals worth $632K as of Q3 2026.
  • Dynasty Wealth Management bought 501 Ionis Pharmaceuticals shares in Q3 2026, an estimated $28.5K.
  • Ionis Pharmaceuticals made up ﹤0.01% of Dynasty Wealth Management's portfolio in Q3 2026, its #216 holding.
  • Dynasty Wealth Management first reported a position in Ionis Pharmaceuticals in Q3 2025 and has held it in 5 quarters since.
  • Dynasty Wealth Management's Ionis Pharmaceuticals position peaked at $1.11M in Q4 2025.
  • 458 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2026.

Based on Dynasty Wealth Management's 13F filing for Q3 2026, filed 12 Nov 2026.